EXHIBIT 99.2
|
Auna S.A. and Subsidiaries
December 31, 2025 |
Auna S.A. and Subsidiaries
Consolidated Financial Statements
December 31, 2025
| Contents | Page |
| Consolidated Statement of Financial Position | 1 |
| Consolidated Statement of Profit or Loss and Other Comprehensive Income | 2 |
| Consolidated Statement of Changes in Equity | 3 |
| Consolidated Statement of Cash Flows | 4 |
| Operating Segments | 5 - 9 |
| Auna S.A. and Subsidiaries |
| Consolidated Statement of Financial Position |
| As of December 31, 2025, 2024 and 2023 |
| In thousands of soles | 2025 | 2024 | 2023 | In thousands of soles | 2025 | 2024 | 2023 | |||
| Assets | Liabilities | |||||||||
| Current assets | Current liabilities | |||||||||
| Cash and cash equivalents | 335,441 | 235,745 | 241,133 | Loans and borrowings | 316,339 | 654,233 | 385,300 | |||
| Trade accounts receivable | 1,042,792 | 961,886 | 860,916 | Lease liabilities | 29,282 | 32,459 | 31,867 | |||
| Other assets | 258,511 | 253,283 | 222,728 | Trade accounts payable | 1,053,395 | 931,265 | 749,349 | |||
| Inventories | 164,798 | 143,764 | 130,521 | Other accounts payable | 225,465 | 289,563 | 463,600 | |||
| Derivative financial instruments | - | 8,962 | 721 | Provisions | 10,161 | 12,246 | 19,074 | |||
| Other investments | 30,237 | 100,228 | 93,132 | Derivative financial instruments | 22,903 | 15,273 | - | |||
| Insurance contract assets | 12,778 | - | - | Insurance contract liabilities | 9,447 | 10,098 | 39,853 | |||
| Total current assets | 1,844,557 | 1,703,868 | 1,549,151 | Deferred income | 98 | 138 | 267 | |||
| Total current liabilities | 1,667,090 | 1,945,275 | 1,689,310 | |||||||
| Non-current assets | ||||||||||
| Trade accounts receivable | 486 | 571 | 420 | Non-current liabilities | ||||||
| Other assets | 26,910 | 24,433 | 21,573 | Loans and borrowings | 3,216,171 | 2,965,541 | 3,376,282 | |||
| Investments in associates and joint venture | 29,848 | 25,405 | 20,584 | Lease liabilities | 94,237 | 115,429 | 126,178 | |||
| Property, furniture, and equipment | 2,287,002 | 2,280,123 | 2,573,140 | Trade accounts payable | 1,450 | 2,741 | 3,906 | |||
| Intangible assets | 2,704,351 | 2,656,888 | 3,129,187 | Other accounts payable | 221,940 | 73,150 | 221,132 | |||
| Right-of-use assets | 113,116 | 131,062 | 139,386 | Derivative financial instruments | 39,647 | 27,097 | - | |||
| Investment properties | 6,340 | 6,058 | 6,959 |
Deferred tax liabilities Deferred income |
291,086 87 |
328,370 177 |
495,826 352 | |||
| Derivative financial instruments | 54,036 | 58,510 | 81,492 | |||||||
| Deferred tax assets | 230,716 | 193,520 | 167,371 | Total non-current liabilities | 3,864,618 | 3,512,505 | 4,223,676 | |||
| Other investments | 702 | 282 | 289 | Total liabilities | 5,531,708 | 5,457,780 | 5,912,986 | |||
| Total non-current assets | 5,453,507 | 5,376,852 | 6,140,401 | Equity | ||||||
| Share capital | 17,389 | 17,387 | 8,820 | |||||||
| Share premium | 1,209,715 | 1,208,586 | - | |||||||
| Reserves | 566,271 | 524,776 | 1,823,364 | |||||||
| Retained losses | (192,615) | (273,533) | (366,899) | |||||||
| Equity attributable to the owner of the Company | 1,600,760 | 1,477,216 | 1,465,285 | |||||||
| Non-controlling interest | 165,596 | 145,724 | 311,281 | |||||||
| Total equity | 1,766,356 | 1,622,940 | 1,776,566 | |||||||
| Total assets | 7,298,064 | 7,080,720 | 7,689,552 | Total liabilities and equity | 7,298,064 | 7,080,720 | 7,689,552 |
1
| Auna S.A. and Subsidiaries |
| Consolidated Statement of Profit or Loss and Other Comprehensive Income |
| For the years ended December 31, 2025, 2024 and 2023 |
| In thousands of soles | 2025 | 2024 | 2023 | |
| Revenue | ||||
| Insurance revenue | 1,131,455 | 1,052,958 | 914,182 | |
| Healthcare services revenue | 2,918,881 | 3,012,454 | 2,695,860 | |
| Sales of medicines | 334,962 | 320,700 | 265,865 | |
| Total revenue from contracts with customers | 4,385,298 | 4,386,112 | 3,875,907 | |
| Cost of sales and services | (2,721,585) | (2,660,819) | (2,440,561) | |
| Gross profit | 1,663,713 | 1,725,293 | 1,435,346 | |
| Selling expenses | (220,859) | (197,475) | (193,943) | |
| Administrative expenses | (812,672) | (788,677) | (704,565) | |
| Loss for impairment of trade receivables | (48,054) | (40,855) | (5,684) | |
| Other expenses | - | (2,112) | (20,927) | |
| Other income | 43,164 | 87,586 | 50,113 | |
| Operating profit | 625,292 | 783,760 | 560,340 | |
| Finance income | 21,833 | 24,810 | 17,126 | |
| Finance income from exchange difference | 193,004 | - | 75,852 | |
| Finance costs | (651,290) | (591,884) | (783,782) | |
| Finance costs from exchange difference | - | (41,709) | - | |
| Net finance cost | (436,453) | (608,783) | (690,804) | |
| Share of profit of equity-accounted investees | 10,414 | 8,800 | 6,290 | |
| Income (loss) before tax | 199,253 | 183,777 | (124,174) | |
| Income tax expense | (88,353) | (59,819) | (90,170) | |
| Profit (loss) for the year | 110,900 | 123,958 | (214,344) | |
| Other comprehensive income | ||||
| Items that are or may be reclassified subsequently to profit or loss | ||||
| Cash flow hedges | (292) | 3,768 | 13,762 | |
| Foreign operations – Foreign currency translation differences | 90,704 | (409,746) | 390,180 | |
| Remeasurements of defined benefit liability | (78) | 1,523 | (2,202) | |
| Change in fair value of put liability | - | - | 40,430 | |
| Other investments at FVOCI – net change in fair value | (1,147) | 1,072 | 188 | |
| Equity-accounted investees – share of OCI | - | - | (42) | |
| Income tax | 248 | (1,744) | (4,305) | |
| Other comprehensive income (loss) for the year, net of tax |
89,435 | (405,127) | 438,011 | |
| Total comprehensive income (loss) for the year | 200,335 | (281,169) | 223,667 | |
| Income (loss) attributable to: | ||||
| Owner of the Company | 97,614 | 110,271 | (253,921) | |
| Non-controlling interest | 13,286 | 13,687 | 39,577 | |
| 110,900 | 123,958 | (214,344) | ||
| Total comprehensive income (loss) attributable to: | ||||
| Owner of the Company | 180,463 | (276,855) | 84,292 | |
| Non-controlling interest | 19,872 | (4,314) | 139,375 | |
| 200,335 | (281,169) | 223,667 | ||
| Earnings (loss) per share | ||||
| Basic earnings per share | 1.32 | 1.64 | (5.78) | |
| Diluted earnings per share | 1.32 | 1.63 | (5.78) |
2
| Auna S.A. and Subsidiaries |
| Consolidated Statement of Changes in Equity |
| For the years ended December 31, 2025, 2024 and 2023 |
| Equity attributable to the owner of the Company | |||||||||||||
| In thousands of soles |
Share capital |
Share premium |
Other capital reserve |
Translation reserve | Cost of hedging reserve |
Hedging reserve |
Merger and other reserves |
Shared- based payment reserve |
Retained earnings (losses) |
Total | Non- controlling interest |
Total equity | |
| Balances as of January 1, 2023 | 236,547 | 386,045 | 56,314 | (190,389) | (15,133) | (16,756) | 699,333 | - | (90,982) | 1,064,979 | 493,082 | 1,558,061 | |
| Loss for the year | - | - | - | - | - | - | - | - | (253,921) | (253,921) | 39,577 | (214,344) | |
| Other comprehensive income for the year | - | - | - | 302,095 | 28,839 | (23,191) | 30,470 | - | - | 338,213 | 99,798 | 438,011 | |
| Total comprehensive income for the year | - | - | - | 302,095 | 28,839 | (23,191) | 30,470 | - | (253,921) | 84,292 | 139,375 | 223,667 | |
| Transfer to legal reserve | - | - | 23,468 | - | - | - | - | - | (23,468) | - | - | - | |
| Changes of participation NCI in subsidiary | - | - | - | 28,360 | (7,284) | 10,399 | 283,892 | - | - | 315,367 | (315,367) | - | |
| Contributions from non-controlling Shareholder | - | - | - | - | - | - | (1,016) | - | - | (1,016) | 1,032 | 16 | |
| Shareholder’s downstream merger | (227,727) | (386,045) | - | - | - | - | 613,963 | - | (2,203) | (2,012) | - | (2,012) | |
| Dividend distribution | - | - | - | - | - | - | - | - | - | - | (6,841) | (6,841) | |
| Equity-settled share-based payment | - | - | - | - | - | - | - | - | 3,675 | 3,675 | - | 3,675 | |
| Total transactions with the owners of the Company | (227,727) | (386,045) | 23,468 | 28,360 | (7,284) | 10,399 | 896,839 | - | (21,996) | 316,014 | (321,176) | (5,162) | |
| Balances as of December 31, 2023 | 8,820 | - | 79,782 | 140,066 | 6,422 | (29,548) | 1,626,642 | - | (366,899) | 1,465,285 | 311,281 | 1,776,566 | |
| Balances as of January 1, 2024 | 8,820 | - | 79,782 | 140,066 | 6,422 | (29,548) | 1,626,642 | - | (366,899) | 1,465,285 | 311,281 | 1,776,566 | |
| Profit for the year | - | - | - | - | - | - | - | - | 110,271 | 110,271 | 13,687 | 123,958 | |
| Other comprehensive loss the year | - | - | - | (391,745) | 8,970 | (6,946) | 2,595 | - | - | (387,126) | (18,001) | (405,127) | |
| Total comprehensive loss for the year | - | - | - | (391,745) | 8,970 | (6,946) | 2,595 | - | 110,271 | (276,855) | (4,314) | (281,169) | |
| Issuance of common stock, net of issuance costs | 1,112 | 1,204,913 | - | - | - | - | - | - | - | 1,206,025 | - | 1,206,025 | |
| Transfer to legal reserve | - | - | 13,230 | - | - | - | - | - | (13,230) | - | - | - | |
| Capitalization of merger reserve | 7,453 | - | - | - | - | - | (7,453) | - | - | - | - | - | |
| Reclassification of shared-based payment reserve | - | - | - | - | - | - | - | 3,675 | (3,675) | - | - | - | |
| Changes of participation NCI in subsidiary | 183 | 183 | (183) | - | |||||||||
| Issuance of shares | 2 | 3,673 | - | - | - | - | - | (3,675) | - | - | - | - | |
| Acquisition of non-controlling interest | - | - | - | 18,909 | - | - | (1,076,628) | - | - | (1,057,719) | (159,910) | (1,217,629) | |
| Derecognition of put liability | - | - | - | - | - | - | 131,152 | - | - | 131,152 | - | 131,152 | |
| Dividend distribution | - | - | - | - | - | - | - | - | - | - | (1,150) | (1,150) | |
| Equity-settled share-based payment | - | - | - | - | - | - | - | 9,145 | - | 9,145 | - | 9,145 | |
| Total transactions with the owners of the Company | 8,567 | 1,208,586 | 13,230 | 18,909 | - | - | (952,746) | 9,145 | (16,905) | 288,786 | (161,243) | 127,543 | |
| Balances as of December 31, 2024 | 17,387 | 1,208,586 | 93,012 | (232,770) | 15,392 | (36,494) | 676,491 | 9,145 | (273,533) | 1,477,216 | 145,724 | 1,622,940 | |
| Balances as of January 1, 2025 | 17,387 | 1,208,586 | 93,012 | (232,770) | 15,392 | (36,494) | 676,491 | 9,145 | (273,533) | 1,477,216 | 145,724 | 1,622,940 | |
| Profit for the year | - | - | - | - | - | - | - | - | 97,614 | 97,614 | 13,286 | 110,900 | |
| Other comprehensive income (loss) for the year | - | - | - | 84,118 | (36,538) | 36,494 | (1,225) | - | 82,849 | 6,586 | 89,435 | ||
| Total comprehensive income (loss) for the year | - | - | 84,118 | (36,538) | 36,494 | (1,225) | 97,614 | 180,463 | 19,872 | 200,335 | |||
| Issuance of shares | 2 | 1,129 | - | - | - | - | - | (1,131) | - | - | - | - | |
| Equity transaction for mandatory purchase of NCI | - | - | - | - | - | - | (68,111) | - | - | (68,111) | - | (68,111) | |
| Transfer to legal reserve | - | - | 16,696 | - | - | - | - | - | (16,696) | - | - | ||
| Equity-settled share-based payment | - | - | - | - | - | - | - | 11,192 | - | 11,192 | - | 11,192 | |
| Total transactions with the owners of the Company | 2 | 1,129 | 16,696 | - | - | - | (68,111) | 10,061 | (16,696) | (56,919) | - | (56,919) | |
| Balances as of December 31, 2025 | 17,389 | 1,209,715 | 109,708 | (148,652) | (21,146) | - | 607,155 | 19,206 | (192,615) | 1,600,760 | 165,596 | 1,766,356 | |
3
| Auna S.A. and Subsidiaries |
| Consolidated Statement of Cash Flows |
| For the years ended December 31, 2025, 2024 and 2023 |
| In thousands of soles | 2025 | 2024 | 2023 |
| Cash flows from operating activities | |||
| Profit (loss) for the year | 110,900 | 123,958 | (214,344) |
| Adjustments for: | |||
| Depreciation | 115,417 | 115,237 | 132,442 |
| Depreciation of right-of-use assets | 28,233 | 27,636 | 26,577 |
| Amortization | 78,781 | 76,273 | 76,731 |
| Change in fair value of investment property | (106) | (161) | (116) |
| Impairment (reversal) of inventories | 668 | 419 | (1,927) |
| Equity-settled share-based payment transactions | 11,192 | 9,145 | 3,675 |
| Gain (loss) on disposal of property, furniture, and equipment | (512) | 4,491 | (696) |
| Gain (loss) on disposal of right-of-use assets net of leases | (20) | 79 | 743 |
| Loss on disposal of intangibles | 147 | 1,117 | 477 |
| Other expenses for derecognition of other assets | - | 2,112 | - |
| Other expenses for changes in contingent consideration | - | - | 20,927 |
| Other income for reversal of contingent consideration | - | - | (4,095) |
| Other income for reversal of others accounts payable to former shareholders | - | (46,613) | - |
| Loss for impairment of trade receivables | 48,054 | 40,855 | 5,684 |
| Share of profit of equity-accounted investees | (10,414) | (8,800) | (6,290) |
| Provisions | 1,344 | 1,001 | 1,176 |
| Finance income | (214,837) | (24,810) | (92,978) |
| Finance costs | 651,290 | 633,593 | 783,782 |
| Income tax expense | 88,353 | 59,819 | 90,170 |
| Net changes in assets and liabilities | |||
| Trade accounts receivable and other assets | (81,630) | (343,151) | (316,000) |
| Inventories | (17,849) | (25,853) | (30,107) |
| Trade accounts payable and other accounts payable | 64,604 | 229,751 | 183,740 |
| Provisions and employee benefits | (3,716) | (5,718) | (4,328) |
| Insurance contract liabilities | (13,465) | (28,602) | 25,068 |
| Cash generated from operating activities | 856,434 | 841,778 | 680,311 |
| Income tax paid | (209,005) | (194,322) | (114,726) |
| Interest received | 15,074 | 21,042 | 16,828 |
| Net cash from operating activities | 662,503 | 668,498 | 582,413 |
| Cash flows from investing activities | |||
| Acquisition of subsidiary, net of cash acquired | - | - | (59,994) |
| Payment for accounts payable to former shareholder | (21,145) | (30,011) | (1,368) |
| Purchase of properties, furniture, and equipment | (86,010) | (90,857) | (116,248) |
| Purchase of intangibles | (58,671) | (50,991) | (48,917) |
| Dividends from equity-accounted investees | 3,378 | 3,311 | 1,439 |
| Other assets (Trust funds) | - | - | 94,539 |
| Purchase of other investments, net of sales | 75,685 | (21,312) | (22,246) |
| Proceeds from sale of property, furniture, and equipment | 6,508 | 213 | 4,194 |
| Payment for contingent consideration | - | (47,174) | (36,143) |
| Proceeds from (payment in advance for) purchase of shares | - | - | 11,592 |
| Net cash used in investing activities | (80,255) | (236,821) | (173,152) |
| Cash flows from financing activities | |||
| Proceeds from issuance of common stock in initial public offering, net of issuance costs | - | 1,267,794 | - |
| Payments of initial public offering costs | - | (15,908) | - |
| Proceeds from loans and borrowings | 4,097,522 | 1,239,486 | 4,871,380 |
| Payment for loans and borrowings | (4,022,294) | (1,125,622) | (4,520,827) |
| Payment for lease liabilities | (43,851) | (45,593) | (42,530) |
| Penalty paid for debt prepayment | (81) | - | (53,285) |
| Payment for derivatives premiums | (22,804) | (50,705) | (51,141) |
| Payment for costs of extinguishment of debt | (64,818) | (16,607) | - |
| Interest paid | (408,268) | (450,982) | (566,774) |
| Proceeds from settlement of derivatives - interest rate swaps | (22,504) | (1,202) | - |
| Dividends paid | - | (1,150) | (6,841) |
| Contributions from non-controlling shareholders | - | - | 16 |
| Acquisition of non-controlling interest | - | (1,217,629) | - |
| Net cash used in from financing activities | (487,098) | (418,118) | (370,002) |
| Net increase in cash and cash equivalents | 95,150 | 13,559 | 39,259 |
| Cash and cash equivalents at January 1 | 235,745 | 241,133 | 208,694 |
| Effect of movements in exchange rates on cash held | 4,546 | (18,947) | (6,820) |
| Cash and cash equivalents at December 31 | 335,441 | 235,745 | 241,133 |
| Transactions not representing cash flows | |||
| Assets acquired through finance lease and other financing | 14,737 | 26,826 | 17,892 |
| Assets acquired from suppliers in installments | 18,365 | 10,060 | 16,834 |
4
| Auna S.A. and Subsidiaries |
| Notes to the Consolidated Financial Statements |
| December 31, 2025, 2024 and 2023 |
Operating Segments
| A. | Basis for segmentation |
The Group has determined four reportable segments. These operating segments are components of a company about which separate financial information is available that is regularly evaluated by the Board of Directors (Chief operating decision maker) in deciding how to allocate resources and assess performance.
The following summary describes the operations of each reportable segment.
| Reportable segments | Operations |
| Oncosalud Peru | Including our prepaid oncologic healthcare plans and healthcare services related to the treatment of cancer. |
| Healthcare services in Peru | Corresponds to medical services within the network of clinics and health centers in Peru. |
| Healthcare services in Colombia | Corresponds to medical services within the network of clinics and health centers in Colombia. |
| Healthcare services in Mexico | Corresponds to medical services within the network of clinics and health centers, and the insurance business in Mexico. |
| B. | Information about reportable segments |
Information related to each reportable segment is set out below. Segment profit (loss) before tax is used to measure performance because the chief operating decision maker believes that this information is the most relevant for the Group.
5
| Auna S.A. and Subsidiaries |
| Notes to the Consolidated Financial Statements |
| December 31, 2025, 2024 and 2023 |
| Reportable segments | |||||||
| In thousands of soles | Oncosalud Peru |
Healthcare services in Peru |
Healthcare services in Colombia | Healthcare services in Mexico |
Total reportable segments |
Holding and eliminations | Total |
| 2025 | |||||||
| External revenues | 1,125,381 | 786,227 | 1,434,924 | 1,038,766 | 4,385,298 | - | 4,385,298 |
| Inter-segment revenue (i) | 38,868 | 298,046 | 5,180 | - | 342,094 | (342,094) | - |
| Segment revenue | 1,164,249 | 1,084,273 | 1,440,104 | 1,038,766 | 4,727,392 | (342,094) | 4,385,298 |
| External cost of service | (316,390) | (730,670) | (1,054,171) | (620,354) | (2,721,585) | - | (2,721,585) |
| Inter-segment cost of service (i) | (295,276) | (35,266) | - | - | (330,542) | 330,542 | - |
| Segment cost of service | (611,666) | (765,936) | (1,054,171) | (620,354) | (3,052,127) | 330,542 | (2,721,585) |
| Gross profit | 552,583 | 318,337 | 385,933 | 418,412 | 1,675,265 | (11,552) | 1,663,713 |
| External selling expenses | (180,342) | (22,654) | (5,373) | (13,836) | (222,205) | 1,346 | (220,859) |
| Segment selling expenses | (180,342) | (22,654) | (5,373) | (13,836) | (222,205) | 1,346 | (220,859) |
| External administrative expenses | (75,148) | (121,765) | (201,976) | (237,401) | (636,290) | - | (636,290) |
| Inter-segment administrative expenses | (5,061) | (7,631) | - | - | (12,692) | 12,692 | - |
| Corporate expenses | (75,936) | (64,811) | (14,389) | (12,690) | (167,826) | (8,556) | (176,382) |
| Segment administrative expenses | (156,145) | (194,207) | (216,365) | (250,091) | (816,808) | 4,136 | (812,672) |
| Impairment losses on trade receivables | (2,563) | (16,807) | (24,918) | (4,138) | (48,426) | 372 | (48,054) |
| Other expenses | (11,156) | (1,191) | - | - | (12,347) | 12,347 | - |
| Other income | 2,789 | 6,978 | 8,940 | 29,901 | 48,608 | (5,444) | 43,164 |
| Inter-segment other income | 12,797 | 966 | - | - | 13,763 | (13,763) | - |
| Other income | 15,586 | 7,944 | 8,940 | 29,901 | 62,371 | (19,207) | 43,164 |
| Segment operating profit (loss) | 217,963 | 91,422 | 148,217 | 180,248 | 637,850 | (12,558) | 625,292 |
| Share of profit of equity accounted investees, net of taxes | 3,278 | - | 7,136 | - | 10,414 | - | 10,414 |
| Exchange difference, net | 1,996 | 4,460 | 73,491 | 16,090 | 96,037 | 96,967 | 193,004 |
| Interest expense, net | (17,151) | (37,995) | (95,064) | (245,843) | (396,053) | (233,404) | (629,457) |
| Segment profit (loss) before tax | 206,086 | 57,887 | 133,780 | (49,505) | 348,248 | (148,995) | 199,253 |
| Other disclosures | |||||||
| Depreciation and amortization | (35,728) | (48,537) | (41,242) | (86,224) | (211,731) | (10,700) | (222,431) |
| Capital expenditure | (22,793) | (33,731) | (23,004) | (50,344) | (129,872) | (11,181) | (141,053) |
| Segment assets | 2,408,375 | 1,032,322 | 2,464,878 | 3,144,939 | 9,050,514 | (1,752,450) | 7,298,064 |
| Segment liabilities | 1,113,312 | 618,896 | 1,361,484 | 1,959,986 | 5,053,678 | 478,030 | 5,531,708 |
6
| Auna S.A. and Subsidiaries |
| Notes to the Consolidated Financial Statements |
| December 31, 2025, 2024 and 2023 |
| Reportable segments | |||||||
| In thousands of soles | Oncosalud Peru |
Healthcare services in Peru |
Healthcare services in Colombia | Healthcare services in Mexico |
Total reportable segments |
Holding and eliminations | Total |
| 2024 | |||||||
| External revenues | 1,030,432 | 718,051 | 1,443,032 | 1,194,597 | 4,386,112 | - | 4,386,112 |
| Inter-segment revenue (i) | 40,188 | 277,701 | - | - | 317,889 | (317,889) | - |
| Segment revenue | 1,070,620 | 995,752 | 1,443,032 | 1,194,597 | 4,704,001 | (317,889) | 4,386,112 |
| External cost of service | (307,047) | (671,370) | (1,040,646) | (641,756) | (2,660,819) | - | (2,660,819) |
| Inter-segment cost of service (i) | (279,344) | (36,596) | - | - | (315,940) | 315,940 | - |
| Segment cost of service | (586,391) | (707,966) | (1,040,646) | (641,756) | (2,976,759) | 315,940 | (2,660,819) |
| Gross profit | 484,229 | 287,786 | 402,386 | 552,841 | 1,727,242 | (1,949) | 1,725,293 |
| External selling expenses | (159,619) | (19,552) | (5,689) | (11,948) | (196,808) | (667) | (197,475) |
| Segment selling expenses | (159,619) | (19,552) | (5,689) | (11,948) | (196,808) | (667) | (197,475) |
| External administrative expenses | (78,596) | (107,736) | (197,887) | (249,202) | (633,421) | - | (633,421) |
| Inter-segment administrative expenses | (369) | (5,593) | - | - | (5,962) | 5,962 | - |
| Corporate expenses | (64,885) | (63,407) | (11,542) | (6,567) | (146,401) | (8,855) | (155,256) |
| Segment administrative expenses | (143,850) | (176,736) | (209,429) | (255,769) | (785,784) | (2,893) | (788,677) |
| Impairment losses on trade receivables | (511) | (7,914) | (28,397) | (3,987) | (40,809) | (46) | (40,855) |
| Other expenses | - | - | - | - | - | (2,112) | (2,112) |
| Other income | 3,196 | 7,386 | 9,438 | 68,818 | 88,838 | (1,252) | 87,586 |
| Inter-segment other income | 10,859 | 948 | - | - | 11,807 | (11,807) | - |
| Other income | 14,055 | 8,334 | 9,438 | 68,818 | 100,645 | (13,059) | 87,586 |
| Segment operating profit (loss) | 194,304 | 91,918 | 168,309 | 349,955 | 804,486 | (20,726) | 783,760 |
| Share of profit of equity accounted investees, net of taxes | 3,305 | - | 5,495 | - | 8,800 | - | 8,800 |
| Exchange difference, net | (1,710) | (1,189) | (67,555) | (20,823) | (91,277) | 49,568 | (41,709) |
| Interest expense, net | (30,833) | (46,346) | (108,301) | (264,340) | (449,820) | (117,254) | (567,074) |
| Segment profit (loss) before tax | 165,066 | 44,383 | (2,052) | 64,792 | 272,189 | (88,412) | 183,777 |
| Other disclosures | |||||||
| Depreciation and amortization | (32,651) | (42,818) | (42,404) | (92,070) | (209,943) | (9,203) | (219,146) |
| Capital expenditure | (31,974) | (45,180) | (43,614) | (36,436) | (157,204) | (21,530) | (178,734) |
| Segment assets | 2,260,833 | 1,034,399 | 2,299,375 | 3,079,407 | 8,674,014 | (1,593,294) | 7,080,720 |
| Segment liabilities | 1,105,230 | 663,499 | 1,359,899 | 1,881,392 | 5,010,020 | 447,760 | 5,457,780 |
7
| Auna S.A. and Subsidiaries |
| Notes to the Consolidated Financial Statements |
| December 31, 2025, 2024 and 2023 |
| Reportable segments | |||||||
| In thousands of soles | Oncosalud Peru |
Healthcare services in Peru |
Healthcare services in Colombia | Healthcare services in Mexico |
Total reportable segments |
Holding and eliminations | Total |
| 2023 | |||||||
| External revenues | 895,507 | 657,923 | 1,192,089 | 1,130,388 | 3,875,907 | - | 3,875,907 |
| Inter-segment revenue (i) | 36,173 | 225,966 | - | - | 262,139 | (262,139) | - |
| Segment revenue | 931,680 | 883,889 | 1,192,089 | 1,130,388 | 4,138,046 | (262,139) | 3,875,907 |
| External cost of service | (277,611) | (645,375) | (853,887) | (663,688) | (2,440,561) | - | (2,440,561) |
| Inter-segment cost of service (i) | (225,196) | (34,297) | - | - | (259,493) | 259,493 | - |
| Segment cost of service | (502,807) | (679,672) | (853,887) | (663,688) | (2,700,054) | 259,493 | (2,440,561) |
| Gross profit | 428,873 | 204,217 | 338,202 | 466,700 | 1,437,992 | (2,646) | 1,435,346 |
| External selling expenses | (163,299) | (18,065) | (6,313) | (5,518) | (193,195) | (748) | (193,943) |
| Segment selling expenses | (163,299) | (18,065) | (6,313) | (5,518) | (193,195) | (748) | (193,943) |
| External administrative expenses | (72,532) | (94,553) | (176,915) | (211,816) | (555,816) | - | (555,816) |
| Inter-segment administrative expenses | (908) | (4,658) | - | - | (5,566) | 5,566 | - |
| Corporate expenses | (63,867) | (60,072) | (11,810) | (8,772) | (144,521) | (4,228) | (148,749) |
| Segment administrative expenses | (137,307) | (159,283) | (188,725) | (220,588) | (705,903) | 1,338 | (704,565) |
| Impairment losses on trade receivables | (355) | 142 | (6,352) | 1,097 | (5,468) | (216) | (5,684) |
| Other expenses | (4,479) | - | (20,302) | - | (24,781) | 3,854 | (20,927) |
| Other income | 1,388 | 8,384 | 16,223 | 26,157 | 52,152 | (2,039) | 50,113 |
| Inter-segment other income | 11,001 | 966 | - | - | 11,967 | (11,967) | - |
| Other income | 12,389 | 9,350 | 16,223 | 26,157 | 64,119 | (14,006) | 50,113 |
| Segment operating profit (loss) | 135,822 | 36,361 | 132,733 | 267,848 | 572,764 | (12,424) | 560,340 |
| Share of profit of equity accounted investees, net of taxes | 2,227 | - | 4,063 | - | 6,290 | - | 6,290 |
| Exchange difference, net | (5,741) | (1,783) | 119,884 | 74,020 | 186,380 | (110,528) | 75,852 |
| Interest expense, net | (24,909) | (45,770) | (109,508) | (385,597) | (565,784) | (200,872) | (766,656) |
| Segment profit (loss) before tax | 107,399 | (11,192) | 147,172 | (43,729) | 199,650 | (323,824) | (124,174) |
| Other disclosures | |||||||
| Depreciation and amortization | (31,968) | (38,997) | (40,226) | (115,650) | (226,841) | (8,909) | (235,750) |
| Capital expenditure | (26,385) | (27,256) | (81,965) | (49,023) | (184,629) | (15,262) | (199,891) |
| Segment assets | 2,146,867 | 889,286 | 2,435,123 | 3,763,000 | 9,234,276 | (1,544,724) | 7,689,552 |
| Segment liabilities | 1,101,354 | 565,754 | 1,514,739 | 2,343,238 | 5,525,085 | 387,901 | 5,912,986 |
8
| Auna S.A. and Subsidiaries |
| Notes to the Consolidated Financial Statements |
| December 31, 2025, 2024 and 2023 |
| (i) | Inter-segment cost of service (claims expense) from the Oncosalud Peru segment and intersegment revenue from our Healthcare Services in Peru segment are presented on a gross basis by adding the corresponding profit margin markup by our Healthcare Services in Peru segment and vice versa. Likewise, our Oncosalud Peru segment consolidates Oncocenter Perú S.A.C., a subsidiary providing healthcare services related to the exclusive treatment of cancer. In the separate financial statements of Oncocenter Perú S.A.C., the revenue mainly consists of the insurance claims expense recorded as cost of sales in the separate financial statements of Oncosalud S.A.C., our insurance subsidiary that is also consolidated in Oncosalud Peru segment. In the segment consolidation process, the related revenues from such healthcare services are eliminated with the corresponding claims expense of our insurance subsidiary Oncosalud S.A.C., while the external cost (third parties) of services incurred by Oncocenter Perú S.A.C. remains. |
| C. | Geographic information |
The geographic information analyzes the Group’s revenue and non-current assets by the country where it operates. In presenting the geographic information, segment revenue has been based on the geographic location of customers and segment assets were based on the geographic location of the assets.
| In thousands of soles | 2025 | 2024 | 2023 |
| Revenue | |||
| Peru | 1,911,608 | 1,748,483 | 1,553,430 |
| Colombia | 1,434,924 | 1,443,032 | 1,192,089 |
| México | 1,038,766 | 1,194,597 | 1,130,388 |
| 4,385,298 | 4,386,112 | 3,875,907 | |
| Non-current assets (*) | |||
| Peru | 909,284 | 908,301 | 871,520 |
| Colombia | 1,478,338 | 1,432,141 | 1,601,604 |
| México | 2,781,133 | 2,784,380 | 3,418,414 |
| 5,168,755 | 5,124,822 | 5,891,538 |
(*) Non-current assets exclude deferred tax assets and derivatives.
| D. | Major customer |
None of the revenue derives from transactions carried out with a single customer or counterparty which is equal to or greater than 10 percent or more of the total revenue of the Group for the years ended December 31, 2025, 2024 and 2023
9